{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:28:25Z","timestamp":1790155705899,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"ERC","award":["290836"],"award-info":[{"award-number":["290836"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.cca.2016.05.017","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T02:36:19Z","timestamp":1464057379000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Accurate quantification of sphingosine-1-phosphate in normal and Fabry disease plasma, cells and tissues by LC-MS\/MS with 13 C-encoded natural S1P as internal standard"],"prefix":"10.1016","volume":"459","author":[{"given":"Mina","family":"Mirzaian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Wisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 R.A.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanit L.","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy P.A.A.","family":"van Roomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelof","family":"Ottenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"van Eijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen D.C.","family":"Cod\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijsbert A.","family":"van der Marel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman S.","family":"Overkleeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2016.05.017_bb0005","series-title":"Sphingosine Biology","first-page":"385","article-title":"Sphingosine-1-phosphate and the regulation of immune cell trafficking","author":"Allende","year":"2006"},{"key":"10.1016\/j.cca.2016.05.017_bb0010","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1194\/jlr.R046300","article-title":"An update on the biology of sphingosine 1-phosphate receptors","volume":"55","author":"Blaho","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2016.05.017_bb0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"Pt 3","key":"10.1016\/j.cca.2016.05.017_bb0020","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj3520809","article-title":"Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions","volume":"352","author":"Murata","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.cca.2016.05.017_bb0025","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1194\/jlr.D008532","article-title":"Blood sphingolipidomics in healthy humans: impact of sample collection methodology","volume":"51","author":"Hammad","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2016.05.017_bb0030","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/ATVBAHA.107.145672","article-title":"Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities","volume":"27","author":"Kontush","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cca.2016.05.017_bb0035","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1194\/jlr.M003988","article-title":"HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate","volume":"51","author":"Lee","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2016.05.017_bb0040","doi-asserted-by":"crossref","first-page":"180705","DOI":"10.1155\/2012\/180705","article-title":"Sphingosine 1-phosphate distribution in human plasma: associations with lipid profiles","volume":"2012","author":"Hammad","year":"2012","journal-title":"J. Lipids"},{"key":"10.1016\/j.cca.2016.05.017_bb0045","first-page":"11","article-title":"Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus","volume":"3","author":"Chiba","year":"2006","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cca.2016.05.017_bb0050","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system","volume":"158","author":"Brinkmann","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cca.2016.05.017_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.expneurol.2015.05.002","article-title":"Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype","volume":"271","author":"Heinen","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cca.2016.05.017_bb0060","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cca.2016.05.017_bb0065","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1523\/JNEUROSCI.3588-15.2016","article-title":"Sphingosine-1-phosphate (S1P) impacts presynaptic functions by regulating Synapsin I localization in the presynaptic compartment","volume":"36","author":"Riganti","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cca.2016.05.017_bb0070","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.biochi.2010.02.008","article-title":"Sphingosine kinase: role in regulation of bioactive sphingolipid mediators in inflammation","volume":"92","author":"Snider","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.cca.2016.05.017_bb0075","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1098\/rstb.2003.1270","article-title":"Future perspectives for glycolipid research in medicine","volume":"358","author":"Cox","year":"2003","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.cca.2016.05.017_bb0080","series-title":"Gaucher Disease","first-page":"97","article-title":"Cellular pathology in Gaucher disease","author":"Futerman","year":"2006"},{"key":"10.1016\/j.cca.2016.05.017_bb0085","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/hmg\/ddn126","article-title":"Sphingosine kinase 1\/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease","volume":"17","author":"Wu","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cca.2016.05.017_bb0090","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.201208152","article-title":"The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction","volume":"199","author":"Platt","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cca.2016.05.017_bb0095","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/nm.1876","article-title":"Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium","volume":"14","author":"Lloyd-Evans","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2016.05.017_bb0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehp387","article-title":"Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease","volume":"31","author":"Brakch","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2016.05.017_bb0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1388-1981(02)00147-6","article-title":"Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?","volume":"1582","author":"Okajima","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2016.05.017_bb0110","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1007\/s00216-015-9008-4","article-title":"Quantification of sphingosine 1-phosphate by validated LC-MS\/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation","volume":"407","author":"Frej","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cca.2016.05.017_bb0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ab.2006.08.027","article-title":"Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction","volume":"358","author":"Andr\u00e9ani","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cca.2016.05.017_bb0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2005.06.040","article-title":"A rapid and validated HPLC method to quantify sphingosine 1-phosphate in human plasma using solid-phase extraction followed by derivatization with fluorescence detection","volume":"824","author":"Butter","year":"2005","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2016.05.017_bb0125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jchromb.2011.10.037","article-title":"Quantification of bioactive sphingo- and glycerophospholipid species by electrospray ionization tandem mass spectrometry in blood","volume":"883-884","author":"Liebisch","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cca.2016.05.017_bb0130","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1021\/ac4039652","article-title":"Lipidomic \u201cdeep profiling\u201d: an enhanced workflow to reveal new molecular species of signaling lipids","volume":"86","author":"Narayanaswamy","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2016.05.017_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bbalip.2010.11.003","article-title":"Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry","volume":"1811","author":"Scherer","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2016.05.017_bb0140","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1373\/clinchem.2008.113779","article-title":"High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry","volume":"55","author":"Scherer","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.05.017_bb0145","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1096\/fj.06-7433com","article-title":"Erythrocytes store and release sphingosine 1-phosphate in blood","volume":"21","author":"H\u00e4nel","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2016.05.017_bb0150","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1194\/jlr.R059543","article-title":"Sources, metabolism, and regulation of circulating sphingosine-1-phosphate","volume":"56","author":"Ksi\u0105\u017cek","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cca.2016.05.017_bb0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1123\/ijsnem.2013-0093","article-title":"Ultramarathon run markedly reduces plasma sphingosine-1-phosphate concentration","volume":"24","author":"Baranowski","year":"2014","journal-title":"Int. J. Sport Nutr. Exerc. Metab."},{"key":"10.1016\/j.cca.2016.05.017_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1373\/clinchem.2012.192138","article-title":"Quantification of globotriaosylsphingosine in plasma and urine of Fabry patients by stable isotope ultraperformance liquid chromatography-tandem mass spectrometry","volume":"59","author":"Gold","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.05.017_bb0165","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1002\/ejoc.201500025","article-title":"Synthesis of a panel of carbon-13-labelled (glyco)sphingolipids","author":"Wisse","year":"2015","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.cca.2016.05.017_bb0170","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"Alpha-galactosidase A deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.cca.2016.05.017_bb0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ymgme.2015.12.006","article-title":"Lyso-glycosphingolipid abnormalities in different murine models of lysosomal storage disorders","volume":"117","author":"Ferraz","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2016.05.017_bb0180","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1373\/clinchem.2006.079012","article-title":"HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma","volume":"53","author":"Groener","year":"2007","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2016.05.017_bb0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bcmd.2015.01.006","article-title":"Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard","volume":"54","author":"Mirzaian","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.cca.2016.05.017_bb0190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.bbalip.2013.11.004","article-title":"Gaucher disease and Fabry disease: new markers and insights in pathophysiology for two distinct glycosphingolipidoses","volume":"1841","author":"Ferraz","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cca.2016.05.017_bb0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tcm.2007.02.006","article-title":"Alpha-galactosidase A in vascular disease","volume":"17","author":"Bodary","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.cca.2016.05.017_bb0200","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.coph.2006.09.008","article-title":"Sphingosine-1-phosphate signaling in the cardiovascular system","volume":"7","author":"Peters","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cca.2016.05.017_bb0205","doi-asserted-by":"crossref","first-page":"ra79","DOI":"10.1126\/scisignal.aaa2581","article-title":"HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation","volume":"8","author":"Galvani","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.cca.2016.05.017_bb0210","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nature14462","article-title":"HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation","volume":"523","author":"Blaho","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cca.2016.05.017_bb0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fendo.2014.00127","article-title":"Podocyte pathology and nephropathy - sphingolipids in glomerular diseases","volume":"5","author":"Merscher","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.cca.2016.05.017_bb0220","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/0192623314565650","article-title":"Reduced activity of sphingosine-1-phosphate lyase induces podocyte-related glomerular proteinuria, skin irritation, and platelet activation","volume":"43","author":"Sch\u00fcmann","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.cca.2016.05.017_bb0225","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2016.05.017_bb0230","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ymgme.2012.03.010","article-title":"Small fiber neuropathy in Fabry disease","volume":"106","author":"Biegstraaten","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2016.05.017_bb0235","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neulet.2015.01.084","article-title":"The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain","volume":"594","author":"Choi","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.cca.2016.05.017_bb0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lfs.2013.06.004","article-title":"Sphingosine lysolipids in the CNS: endogenous cannabinoid antagonists or a parallel pain modulatory system?","volume":"93","author":"Selley","year":"2013","journal-title":"Life Sci."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116302212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898116302212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T18:23:00Z","timestamp":1567966980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898116302212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":48,"alternative-id":["S0009898116302212"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2016.05.017","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accurate quantification of sphingosine-1-phosphate in normal and Fabry disease plasma, cells and tissues by LC-MS\/MS with 13C-encoded natural S1P as internal standard","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2016.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}